Back to search
Carbon Monoxide Exposure
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Carbon Monoxide Exposure trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Carbon Monoxide Exposure trials you may qualify forCarbon monoxide (CO) is a colorless and odorless gas that can enter the human body through environmental exposure and especially tobacco use. CO binds to hemogl…
Prenatal exposure to tobacco smoke, whether from active maternal smoking or secondhand exposure, has been associated with adverse neonatal adaptation, metabolic…
In contrast to toxic CO concentrations, low-dose CO acts as a signaling molecule and can exert many complex cytoprotective effects. Therefore, the effects of lo…
According to the hypothesis of this study presented, the effects of smoking on the fetus can be determined by the liver circulation and hepatic metabolism. The…
Carbon monoxide (CO) is reported to cause around 30 deaths, 200 admissions and 4000 presentations to Emergency Departments each year in the UK. In the longer te…
determination of the half-life of COHb in CO-poisoned patients with high flow nasal oxygen therapy in the ED.
To assess the risk of cardiovascular mortality in workers with increased occupational exposure to carbon monoxide.
The purpose of this study is to determine whether a relationship exists between EtCO2 and carboxyhemoglobin levels in carbon monoxide exposure. Our hypothesis i…